Journals / Ortadoğu Tıp Dergisi / 2026 / Cilt: 10 Sayı: 3

Evaluation of neutrophil / lymphocyte ratio and platelet indexes in endometrium cancer

Endometrium kanserinde nötrofil/lenfosit oranının ve platelet endekslerinin değerlendirilmesi

İlkin Yeral(Kırıkkale Üniversitesi Tıp Fakültesi Kadın Hastalıkları ve Doğum AD)0000-0001-8987-1336
Cemile Dayangan Sayan(Kırıkkale Üniversitesi Tıp Fakültesi Kadın Hastalıkları ve Doğum AD)
Pages
307–311
Publication Date
2018-09-30
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: As a result; inflammation may increase platelet activity and provide a basis for endometrial cancer.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Endometrium cancer is the most common ly seen gynecologic cancer.
📊
Key Findings & Data:Material and Method: The study included a total of 105 patients.
💡
Conclusion & Impact:Conclusion: As a result; inflammation may increase platelet activity and provide a basis for endometrial cancer.
🔬Design:Araştırma Makalesi
📍Scope:Comprehensive Sample
⚙️Variables:Endometrium kanseri · nötrofil/lenfosit oranı · ortalama platelet volümü

Abstract

Aim: Endometrium cancer is the most common ly seen gynecologic cancer. As in all the cancer processes , chronic inflammation plays an etiological role. Material and Method: The study included a total of 105 patients. T hree groups each consisting 35 patients are formed . Based on the results of endometrial sampling, the patients are groped as benign, hyperplasia and malignant . D ifference s of hematologic parameters between the groups w ere investigated. Results: There was no statistically significant difference between the groups in terms of neutrophil, lymphocyte, and platelet count, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio (p>0. 05). Hemoglobin, mean platelet volume and platelet distribution width values ​​ were found statistically significantly higher in the malignant group (p<0.05). Conclusion: As a result; inflammation may increase platelet activity and provide a basis for endometrial cancer.

Özet

Amaç: Jinekolojik kanserler arasında en sık görüleni endometrium kanseridir. Tüm kanserlerde olduğu gibi, endometrium kanserinde de kronik inflamasyon etyolojik faktör olarak rol oynamaktadır. Gereç ve Yöntem: Çalışmamıza her grupta 35 olmak üzere üç grup ve toplam 105 hasta dahil edildi. Endometrial örnekleme sonuçlarına göre gruplar; benign grup, hiperplazi grubu ve malign grup olarak isimlendirildi. Gruplar arasında hematolojik parametrelerde anlamlı fark olup olmadığı araştırıldı. Bulgular: Nötrofil sayısı, lenfosit sayısı, platelet sayısı, nötrofil/lenfosit oranı ve platelet/lenfosit oranı bakımından gruplar arasında istatistiksel olarak anlamlı bir fark saptanmadı (p>0,05). Hemoglobin, ortalama platelet volümü ve Platelet dağılım genişliği değerleri malign grupta istatistiksel olarak anlamlı derecede yüksek saptandı (p<0,05). Sonuç: Çalışmamızda elde ettiğimiz sonuçlar bize; inflamasyonun, platelet aktivitesini arttırarak endometrium kanserine zemin hazırlayabileceğini düşündürdü.

🔖

Cite This Article

Yeral, İ., Sayan, C. D. (2018). Evaluation of neutrophil / lymphocyte ratio and platelet indexes in endometrium cancer. Ortadoğu Tıp Dergisi, Cilt: 10 Sayı: 3, 307–311. https://doi.org/10.21601/ortadogutipdergisi.445159

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Referans1. Elit LM, Pond G, Seow H. Time interval between endometrial biopsy and surgical staging for type I endometrial cancer: association between tumor characteristics and survival outcome. Obstet Gynecol. 2015;125:1497-1498.
  2. Referans2. Kim MK, Seong SJ, Kim JW ve ark. Management of Endometrial Hyperplasia: A Survey of Members of the Korean Gynecologic Oncology Group. Int J Gynecol Cancer. 2015;25:1277-1284.
  3. Referans3. Kim DK, Oh SY, Kwon HC ve ark. Clinical significances of preoperative serum interleukin-6 and C-reactive protein level inoperable gastric cancer. BMC Cancer. 2009;9:155.
  4. Referans4. Mangalpally KK, Siqueiros-Garcia A, Vaduganathan M, Dong JF, Kleiman NS, Guthikonda S. Platelet activation patterns in platelet size sub-populations: differential responses to aspirin in vitro. Journal of Thrombosis and Thrombolysis. 2010;30:251–262.
  5. Referans5. Talhouk A, McConechy MK, Leung S ve ark. A clinically applicable molecular-based classification for endometrial cancers. Br J Cancer. 2015;113:299-310.
  6. Referans6. D. W. Kamp, E. Shacter, and S. A. Weitzman, Chronic inflammation and cancer: the role of the mitochondria. Oncology. 2011;400–413.
  7. Referans7. Arango HA, Icely S, Roberts WS, Cavanagh D, Becker JL. Aspirin effects on endometrial cancer cell growth. Obstet Gynecol 2001;423–427.
  8. Referans8. L. Dossus, S. Rinaldi, S. Becker ve ark. Obesity, inflammatory markers, and endometrial cancer risk: a prospective Case-Control Study. Endocrine-Related Cancer. 2010;1007–1019.
  9. Referans9. Vagdatli E, Gounari E, Lazaridou E, Katsibourlia E, Tsikopoulou F, Labrianou I. Platelet distribution width: a simple, practical and specific marker of activation of coagulation. Hippokratia. 2010;14:28-32.
  10. Referans10. Tuszynski GP, Nicosia RF. The role of thrombospondin-1 in tumor progression and angiogenesis. Bioessays, 1996; 71-76.
  11. Referans11. Oge T, Yalcin OT, Ozalp SS, Isikci T. Platelet volume as a parameter for platelet activation in patients with endometrial cancer. J Obstet Gynaecol. 2013;33:301-304.
  12. Referans12. Ercan Yılmaz, Ebru İnci Coşkun, Nurhan Şahin, Tamer Elkıran, Barış Cıplak, Yavuz Şimşek. The sıgnıfıcance of MPV and N/L value ın dıagnosıs of endometrıal cancer. Türk Jinekolojik Onkoloji Dergisi. 2015;33-36.
  13. Referans13. Karateke A, Kaplanoglu M, Baloglu A. Relations of Platelet Indices with Endometrial Hyperplasia and Endometrial Cancer. Asian Pac J Cancer Prev. 2015;16:4905-4908.
  14. Referans14. Yıldırım MA, Seckin KD, Togrul C ve ark. Roles of neutrophil/lymphocyte and platelet/lymphocyte ratios in the early diagnosis of malignant ovarian masses. Asian Pac J Cancer Prev. 2014;15:6881-6885.
  15. Referans15. Kokcu A, Kurtoglu E, Celik H, Tosun M, Malatyalıoglu E, Ozdemir AZ. May the platelet to lymphocyte ratio be a prognostic factor for epithelial ovarian cancer? Asian Pac J Cancer Prev. 2014;15:9781-9784.